Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ABT 898

Known as: ABT-898, ABT898 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Chronic effects of an anti-angiogenic thrombospondin-1 mimetic peptide, ABT-898, on female mouse reproductive outcomes
BackgroundAngiogenesis is an essential process in endometriosis disease progression. Earlier, we demonstrated that anti… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2015
2015
Thrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis model.
AIM To evaluate the efficacy of the improved thrombospondin mimetic peptide ABT-898 in a murine model of ulcerative colitis… Expand
2015
2015
Compatibility of a Novel Thrombospondin-1 Analog with Fertility and Pregnancy in a Xenograft Mouse Model of Endometriosis
Endometriosis is a gynecological disease defined by the growth of endometrium outside of the uterus. Although endometriosis… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
AI-03TARGETING ANGIOGENESIS WITHOUT INCREASING THE STROMAL CELL RESPONSE OR INVASION USING ABT-898, A THROMBOSPONDIN TYPE 1 REPEAT PEPTIDE.
Anti-angiogenic therapy is a promising therapeutic approach for highly vascularized tumors including glioblastoma (GBM… Expand
2012
2012
Prospective study of thrombospondin-1 mimetic peptides, ABT-510 and ABT-898, in dogs with soft tissue sarcoma.
BACKGROUND Exposure to anti-angiogenic thrombospondin-1 (TSP-1) mimetic peptides (MPs) has resulted in sporadic anti-tumor… Expand
2012
2012
Thrombospondin-1 (TSP-1) analogs ABT-510 and ABT-898 inhibit prolactinoma growth and recover active pituitary transforming growth factor-β1 (TGF-β1).
Prolactinomas are the most prevalent type of secreting pituitary tumors in humans and generally respond well to a medical therapy… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
2012
2012
Thrombospondin-1 mimetic peptide ABT-898 affects neovascularization and survival of human endometriotic lesions in a mouse model.
Endometriosis is a common cause of pelvic pain and infertility in women, and a common indication for hysterectomy, yet the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
ABT-898 Induces Tumor Regression and Prolongs Survival in a Mouse Model of Epithelial Ovarian Cancer
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy and is often not diagnosed until late stages due to its… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
2011
2011
Preclinical Development ABT-898 Induces Tumor Regression and Prolongs Survival in a Mouse Model of Epithelial Ovarian Cancer
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy and is often not diagnosed until late stages due to its… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
2010
2010
A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo.
Using a novel in vitro angiogenesis assay, we previously showed that thrombospondin (TSP)-1 has antiangiogenic effects on rat… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE